©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 110449
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.110449
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.110449
Table 2 Protection mechanisms to liver cells against various toxicities by silybin
| Disease/liver toxicity | Silybin proposed mechanisms | Ref. |
| Acetaminophen, methotrexate, ethanol, carbon tetrachloride toxicity | Decreased cytotoxicity, increased antioxidant enzymes; i.e., SOD, GSH, decreased cytokines production; i.e., IL-1, IL-6, TNF production | [68-71] |
| Free radicals toxicity | Increased antioxidant enzymes, i.e., SOD, glutathione; decreased lipoxygenase and leukotrienes | [70,72] |
| Iron toxicity | Decreased inflammatory cytokines; i.e., TGF-β and interleukins, decreased lipid peroxidation and oxidative damage | [12] |
| Viruses & natural toxins | Decreased alanine transaminase, aspartate transaminase and γ-glutamyl transpeptidase | [72] |
- Citation: Liu XX, Hassan W, Ahmed H, Song SZ. Hepatoprotective effects of silybin in liver fibrosis. World J Gastroenterol 2025; 31(42): 110449
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/110449.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.110449